Search Results for "Experts Discuss TJR, Endpoints, and Pain in Clinical Trials for Osteoarthritis Drug Development"

Experts Discuss TJR, Endpoints, and Pain in Clinical Trials for Osteoarthritis Drug Development

Chronic Pain: Conducting Clinical Trials in Osteoarthritis

FDA Weighs in on Current Status of Osteoarthritis Biomarkers for Drug Development | Greg Levin

Recap - Biomarkers in Osteoarthritis Drug Development | David Felson and Nikolay Nikolov

#NIHHEAL: Endpoints for Pain Clinical Trials — Patient Reported Outcomes

Osteoarthritis Patient-Focused Drug Development Meeting

Management of Osteoarthritis: Current conservative therapeutic approaches

Calling on the Experts: Osteoarthritis

“Exploring The Rapid Rise Of Osteoarthritis” With Eupraxia's (EPRX) CEO Dr. James Helliwell

Clinical Trial for Knee Arthritis- IOF Presentation by Dr Rogers

How the QFR in your cathlab can help us to assess non-invasively the coronary physiology? - Webinar

Tanezumab improves osteoarthritis pain, function in phase 3 trial